Breaking News

Aptuit Appoints CEO

December 2, 2013

Goldman to establish new partnerships and pursue strategic acquisitions

Jonathan Goldman, M.D. has been appointed chief executive officer of Aptuit LLC. Dr. Goldman will focus his efforts on the growth of early development services by establishing new partnerships and pursuing strategic acquisitions. He joins the company from ICON Clinical Research, where he served as executive vice president, global strategic and business development and a member of the senior leadership team.
 
While at ICON, his accomplishments included record growth levels of sales, and the development of business relationships with leading pharma and biopharma companies. Previously, he served as ICON’s executive vice president, operations, strategic programs and chief medical officer, ICON Medical Imaging. Before ICON, Dr. Goldman served as chief medical officer of POINT Biomedical for seven years. He also held honorary academic positions of increasing responsibility at the University of California, most recently as associate Clinical Professor of Medicine in the Division of Cardiology. 
 
Timothy C. Tyson, chairman of Aptuit, said, "We're enthusiastic that Jonathan is joining us. He brings exceptional experience in science, sales and medicine, along with the innate talents that are needed to advance us to the next level of growth and accomplishments. His collaborative approach to understanding and satisfying the unmet needs of our clients makes him the perfect complement to our senior management team."
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks